Teclistamab in Previously Treated AL Amyloidosis

NCT06935162 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking Union Medical College Hospital